Skip to main content
. 2022 Jul 12;14:881–888. doi: 10.2147/IJWH.S372453

Table 1.

Demographics and Clinical Characteristics of the Study Population

Factors Frequency/Mean Died Survived χ2 P-value
Age Group (Years)
<20 7(8.9%) 2(28.6%) 5(71.4%) 9.052 0.029*
20–30 41(52%) 7(17.1%) 34(82.9%)
31–40 29(36.7%) 0(0.0%) 29(100.0%)
>40 2(2.5%) 1(50.0%) 1(50.0%)
Comorbidities
No Comorbid 65(82.3%) 10(15.4%) 55(84.6%) 2.466 0.651
Hypertension 8(10.1%) 0(0.0%) 8(100.0%)
Heart Failure 3(3.8%) 0(0.0%) 3(100.0%)
Diabetes with HTN 2(2.5%) 0(0.0%) 1(100.0%)
Hypothyroidism 1(1.3%) 0(0.0%) 2(100.0%)
Cause of Postpartum AKI
Eclampsia 19(24.1%) 1(5.3%) 18(94.7%) 19.350 0.152
Sepsis 4(5.1%) 2(50%) 2(50%)
Uterine rupture 7(8.9%) 0(0.0%) 7(100.0%)
Placenta previa 2(2.5%) 0(0.0%) 2(100%)
PPH 4(5.1%) 1(25.0%) 3(75.0%)
Intrauterine death 13(16.5%) 1(7.7%) 12(92.3%)
Hemorrhagic Shock 13(16.5%) 3(23.1%) 10(76.9%)
Placenta abruptio 7(8.9%) 0(0.0%) 7(100.0%)
Eclampsia and Sepsis 1(1.3%) 0(0.0%) 1(100.0%)
Uterine rupture Plus Hemorrhagic Shock 2(2.5%) 0(0.0%) 2(100.0%)
Eclampsia Plus Placenta previa Plus Hemorrhagic Shock 1(1.3%) 0 (0.0%) 1(100.0%)
Placenta previa Plus Intrauterine death 1(1.3%) 0 (0.0%) 1(100.0%)
Eclampsia Plus Uterine rupture 3(3.8%) 1(33.3%) 2(66.7%)
Eclampsia Plus Hemorrhagic Shock 1(1.3%) 0(0.0%) 1(100.0%)
Sepsis Plus Hemorrhagic Shock 1(1.3%) 1(100.0%) 0(0.0%)
Urine Output
Anuric 57(72.15%) 7(25.9) 20(74.1) 2.1 0.67
Oliguric 24(27.84%) 3(5.8) 49(94.2)
Duration of stay
5 days 7(30.43) 16(69.56) 9.5 0.009*
5–10 days 11.48±11.02 2(7.69) 24(92.30)
>10 days 1(3.33) 29(96.66)
USG
Not done 8(10.1%) 2(25.0%) 6(75.0%) 4.424 0.219
Normal Abdominal 17(21.5%) 4(23.5%) 13(76.5%)
Renal Parenchymal Disease 51(64.6%) 4(7.8%) 47(92.2%)
Unilateral/Bilateral Renal Atrophy 3(3.8%) 0(0.0%) 3(100.0%)

Note: *p values <0.05 are statistically significant.

Abbreviations: IUD, Intrauterine death; USG, ultrasound AKI acute kidney injury; PPH, postpartum hemorrhage.